We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
OGE Energy
OGE
$10.2B
| $20.6M | 0.28% |
687,580
+129,020
| +23% | +$4.06M |
|
77
McCormick & Company Non-Voting
MKC
$13.5B
| $20.6M | 0.28% |
212,342
-6,086
| -3% | -$596K |
|
78
TJX Companies
TJX
$170B
| $20.6M | 0.28% |
+369,995
| New | +$19.9M |
|
79
Phillips 66
PSX
$83B
| $19.9M | 0.27% |
384,477
+274,323
| +249% | +$16.7M |
|
80
Atlassian
TEAM
$20.3B
| $19.9M | 0.27% |
109,481
+79,376
| +264% | +$14.2M |
|
81
Northrop Grumman
NOC
$75.8B
| $19.7M | 0.27% |
62,346
+7,681
| +14% | +$2.5M |
|
82
Idexx Laboratories
IDXX
$42.5B
| $19.5M | 0.26% |
49,630
+37,048
| +294% | +$13.7M |
|
|
AZPN
83
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $19.3M | 0.26% |
152,700
+22,897
| +18% | +$2.9M |
|
84
Paychex
PAYX
$39.4B
| $19.3M | 0.26% |
241,743
-13,470
| -5% | -$1.01M |
|
85
Broadcom
AVGO
$1.87T
| $19.2M | 0.26% |
+527,280
| New | +$17.7M |
|
86
Adobe
ADBE
$84.3B
| $18.8M | 0.25% |
38,268
-24,203
| -39% | -$11.3M |
|
87
Charter Communications
CHTR
$15.6B
| $18.7M | 0.25% |
29,904
-21,775
| -42% | -$12.8M |
|
88
PUT
Invesco QQQ Trust
QQQ
$460B
| $18.5M | 0.25% |
+66,700
| New | +$18.1M |
|
89
SiriusXM
SIRI
$10.1B
| $18.4M | 0.25% |
343,008
+186,737
| +119% | +$10.7M |
|
90
EOG Resources
EOG
$77.5B
| $18M | 0.24% |
+499,977
| New | +$22.4M |
|
91
BJs Wholesale Club
BJ
$11.7B
| $17.9M | 0.24% |
431,616
-20,618
| -5% | -$852K |
|
92
Vertex Pharmaceuticals
VRTX
$120B
| $17.8M | 0.24% |
65,288
+34,443
| +112% | +$9.5M |
|
|
FISV
93
Fiserv Inc
FISV
$26.6B
| $17.6M | 0.24% |
171,174
-99,488
| -37% | -$9.91M |
|
94
Huntington Ingalls Industries
HII
$11.3B
| $17.6M | 0.24% |
125,243
+50,818
| +68% | +$8.18M |
|
95
Boston Scientific
BSX
$64.8B
| $17.1M | 0.23% |
+447,338
| New | +$17.2M |
|
96
Polaris
PII
$4.13B
| $16.8M | 0.23% |
178,068
+140,536
| +374% | +$13.8M |
|
97
Chubb
CB
$137B
| $16.5M | 0.22% |
141,907
+134,249
| +1,753% | +$16.9M |
|
98
Xcel Energy
XEL
$50.4B
| $16.5M | 0.22% |
238,577
+175,504
| +278% | +$12M |
|
99
Aramark
ARMK
$15B
| $16.4M | 0.22% |
860,969
-55,790
| -6% | -$994K |
|
100
Bank of America
BAC
$430B
| $16.3M | 0.22% |
676,686
+77,899
| +13% | +$1.94M |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.